Avitide
Latest round
- Series E
Last raised
- Jun 2017
Total raised
- $21M
Investors
- 7
About Avitide
Avitide, Inc.Avitide, Inc. was founded in 2012 in Lebanon, US, focusing on the development of purification technologies. The company has engaged in a total of 8 deals, with the most recent deal occurring on October 15, 2019.Avitide specializes in the development and supply of affinity purification solutions tailored for the biopharmaceutical manufacturing industry. The company's core offerings include its proprietary AVIPure™ affinity resins, which are the first and only serotype-specific resins for adeno-associated viruses (AAV) that are regenerable using NaOH.5M NaOH, addressing challenges in the purification processes for a wide range of biopharmaceuticals, including next-generation biotherapeutics.Avitide generates revenue through direct business-to-business transactions in the biopharmaceutical sector, primarily from the sale and licensing of its AVIPure™ affinity resins and purification technologies. The company engages in partnerships and collaborations with biopharmaceutical manufacturers, providing commercial resin supply alongside development support. Agreements with clients often include supply contracts for ongoing production needs, ensuring quality and reliability while meeting clinical and commercial demands. The company aims to introduce these innovative solutions to enhance its product line by the end of 2021. Additionally, Avitide is targeting expansion into new international markets, particularly in Europe and Asia, with plans to establish a presence in these regions by 2023.
Who invested in Avitide
7 investors across 4 rounds
See all investors in Avitide
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Avitide
Who invested in Avitide?
Avitide has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avitide raised?
Avitide has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Avitide last raise money?
Avitide's most recent round on record is a Series E, in Jun 2017.
What does Avitide do?
Avitide is a biotechnology company.
Where is Avitide headquartered?
Avitide is headquartered in Lebanon, US.
Which VCs invest in companies like Avitide?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Avitide's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Avitide? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.